AAAAAA

   
Results: 1-8 |
Results: 8
HYPOCHOLESTEROLEMIC ACTIVITY OF RALOXIFENE (LY139481) - PHARMACOLOGICAL CHARACTERIZATION AS A SELECTIVE ESTROGEN-RECEPTOR MODULATOR
Authors: KAUFFMAN RF BENSCH WR ROUDEBUSH RE COLE HW BEAN JS PHILLIPS DL MONROE A CULLINAN GJ GLASEBROOK AL BRYANT HU
Citation: Rf. Kauffman et al., HYPOCHOLESTEROLEMIC ACTIVITY OF RALOXIFENE (LY139481) - PHARMACOLOGICAL CHARACTERIZATION AS A SELECTIVE ESTROGEN-RECEPTOR MODULATOR, The Journal of pharmacology and experimental therapeutics, 280(1), 1997, pp. 146-153
HYPOCHOLESTEROLEMIC ACTIVITY OF RALOXIFENE (LY13948-CENTER-DOT-HCL) -PHARMACOLOGICAL CHARACTERIZATION AS A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM)
Authors: KAUFFMAN RF BENSCH WR MAGEE DE GLASEBROOK AL BRYANT HU
Citation: Rf. Kauffman et al., HYPOCHOLESTEROLEMIC ACTIVITY OF RALOXIFENE (LY13948-CENTER-DOT-HCL) -PHARMACOLOGICAL CHARACTERIZATION AS A SELECTIVE ESTROGEN-RECEPTOR MODULATOR (SERM), The FASEB journal, 10(3), 1996, pp. 4099-4099
SYNTHESIS AND BIOLOGICAL EVALUATION OF A NEW SERIES OF STEROLS AS POTENTIAL HYPOCHOLESTEROLEMIC AGENTS
Authors: LIN HS RAMPERSAUD AA ARCHER RA PAWLAK JM BEAVERS LS SCHMIDT RJ KAUFFMAN RF BENSCH WR BUMOL TF APELGREN LD EACHO PI PERRY DN MCCLURE DB GADSKI RA
Citation: Hs. Lin et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF A NEW SERIES OF STEROLS AS POTENTIAL HYPOCHOLESTEROLEMIC AGENTS, Journal of medicinal chemistry, 38(2), 1995, pp. 277-288
COMPARATIVE EFFECTS OF LOCAL VS SYSTEMIC ADMINISTRATION OF ESTROGEN UPON VASCULAR-RESPONSES TO BALLOON INJURY
Authors: KAUFFMAN RF BEAN JS BENSCH WR
Citation: Rf. Kauffman et al., COMPARATIVE EFFECTS OF LOCAL VS SYSTEMIC ADMINISTRATION OF ESTROGEN UPON VASCULAR-RESPONSES TO BALLOON INJURY, Circulation, 92(8), 1995, pp. 3013-3013
REDUCTION OF INTIMAL THICKENING BY LOVASTATIN IN THE ABSENCE OF REDUCTIONS IN SERUM-CHOLESTEROL
Authors: KAUFFMAN RE BEAN JS BENSCH WR
Citation: Re. Kauffman et al., REDUCTION OF INTIMAL THICKENING BY LOVASTATIN IN THE ABSENCE OF REDUCTIONS IN SERUM-CHOLESTEROL, The FASEB journal, 8(4), 1994, pp. 10000319-10000319
EFFECTS OF LY295427, A NOVEL HYPOCHOLESTEROLEMIC AGENT, ON LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR GENE-TRANSCRIPTION IN-VITRO AND ON SERUM-CHOLESTEROL IN HYPERCHOLESTEROLEMIC ANIMALS
Authors: BENSCH WR KAUFFMAN RF BEAVERS LS SCHMIDT RJ BEAN JS PERRY DN EACHO PI MCCLURE DB ARCHER RA GADSKI RA
Citation: Wr. Bensch et al., EFFECTS OF LY295427, A NOVEL HYPOCHOLESTEROLEMIC AGENT, ON LOW-DENSITY-LIPOPROTEIN (LDL) RECEPTOR GENE-TRANSCRIPTION IN-VITRO AND ON SERUM-CHOLESTEROL IN HYPERCHOLESTEROLEMIC ANIMALS, The FASEB journal, 8(4), 1994, pp. 10000373-10000373
INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN IN NORMOCHOLESTEROLEMIC AND HYPERCHOLESTEROLEMIC HAMSTERS - EFFECTS ON HDL SUBSPECIES, QUANTITY, AND APOLIPOPROTEIN DISTRIBUTION
Authors: EVANS GF BENSCH WR APELGREN LD BAILEY D KAUFFMAN RF BUMOL TF ZUCKERMAN SH
Citation: Gf. Evans et al., INHIBITION OF CHOLESTERYL ESTER TRANSFER PROTEIN IN NORMOCHOLESTEROLEMIC AND HYPERCHOLESTEROLEMIC HAMSTERS - EFFECTS ON HDL SUBSPECIES, QUANTITY, AND APOLIPOPROTEIN DISTRIBUTION, Journal of lipid research, 35(9), 1994, pp. 1634-1645
RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS
Authors: BLACK LJ SATO M ROWLEY ER MAGEE DE BEKELE A WILLIAMS DC CULLINAN GJ BENDELE R KAUFFMAN RF BENSCH WR FROLIK CA TERMINE JD BRYANT HU
Citation: Lj. Black et al., RALOXIFENE (LY139481 HCL) PREVENTS BONE LOSS AND REDUCES SERUM-CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARIECTOMIZED RATS, The Journal of clinical investigation, 93(1), 1994, pp. 63-69
Risultati: 1-8 |